Скачать или смотреть Is HIMS Stock a buy now after its Crash! (The Truth)

Is HIMS stock a generational buying opportunity or a falling knife? In this episode of 'Is The Bottom In?', we break down Hims & Hers Health (HIMS) following its massive price drop and 688% volume spike. We analyze the impact of the Novo Nordisk lawsuit, FDA regulations on compounded GLP-1s, and the technical chart carnage. Scenarios explored: Bull Case ($36), Base Case ($18.30), and Bear Case ($10.56). Learn why the $14 and $10 levels are critical for investors. Disclaimer: Not financial advice.
HIMS stock, HIMS stock analysis, Hims & Hers Health, GLP-1, Novo Nordisk lawsuit, stock market crash, technical analysis, investing, finance, Is The Bottom In, weight loss drugs, FDA regulations, stock prediction, growth stocks